Introduction
Titin is a large, 3000-3700 kDa myo®brillar protein consisting of a single 27,000-33,000 residue long polypeptide chain that spans the entire halfsarcomere. Titin's N-terminal $80 kDa region is integrated in the Z-line lattice of the striated muscle sarcomere, and its C-terminal $200 kDa region is located in the M-line lattice (for reviews, see Trinick & Tskhovrebova 1 and Gregorio et al. 2 ). In addition to its structural functions, titin also confers elasticity to myo®brils by virtue of its elastic spring elements located in the I-band of the sarcomere (for a review, see Link & Granzier 3 ). It is interesting that titin also contains phosphorylation motifs, calpain-binding sites, and a serine/threonine-kinase domain, suggesting that titin may play a role in myo®brillar signal transduction. [4] [5] [6] [7] In particular, the presence of the catalytic serine/threonine kinase domain of titin, located within its C-terminal region in the M-line peripheral region of the sarcomere, 8 has prompted numerous speculations regarding titin-based myo®brillar signal transduction pathways. For example, the homology of titin's kinase domain to myosin-light chain kinase, and also the twitching phenotype of unc-22 mutants, a titin-homologous gene from Caenorhabditis elegans, 9 raises the possibility that titin/twitchin kinase activities may regulate muscle contraction by phosphorylating myosin/myosin light chains. So far, phosphorylation of myosin/myosin light chains by vertebrate titin has not been demonstrated. It has also been suggested that altering levels of S100/Ca 2 complex dynamically controls twitchin/titin kinase activities, because vertebrate muscle S100 extracts were found to stimulate C. elegans twitchin kinase activity in vitro. 10 It should be noted, however, that the complete C. elegans genome sequence does not contain S100 like genes. 11 Recently, it was suggested that the physiological substrate of the titin kinase domain is the 19 kDa myo®brillar protein telethonin }12 (also called T-cap), 13 and that telethonin and its phosphorylation is critical for myo®brillogenesis. 14 However, more recently, muscular dystrophy patients have been identi®ed who are telethonin-null, 15 yet their myo®brils are structurally normal. Therefore, the role of titin's kinase domain remains elusive.
The kinase domain in the vertebrate titin polypeptide is¯anked by Ig/FN3 domains with sequences and domain organizations that are conserved in titin, the titin-related invertebrate proteins projectin and twitchin, and in the smooth and non-muscle myosin light chain kinases. 4, 9, 16, 17 In titin, this region corresponds to the segment A168-A169-A170-kinase domain-M1-M2-M3 (A168, A169, M1, M2 and M3 all being Ig domains, whereas A170 is an FN3 domain; see Figure 1 ). Here, therefore, we searched for myo®brillar proteins that interact with baits containing titin's A168/kinase/M3 region by using a yeast twohybrid approach. This has led to the identi®cation of the novel RING ®nger protein, MURF-1, that binds N-terminally of the titin kinase domain to the repeats A168/A169. MURF-1 therefore associates with the periphery of the M-line lattice and may be involved in the regulation of the titin kinase domain. Furthermore, since MURF-1 in turn forms heterodimers with two closely related MURFs, one of which has recently been shown to be involved in regulation of microtubule dynamics, 18 the MURF family may link titin ®la-ment-based and microtubule-based signal transduction pathways. 
Results
Specific interaction of MURF-1 and titin kinase flanking modules A168/A169
In order to identify sarcomeric proteins that may bind to the titin kinase region, yeast two-hybrid screens were performed with baits corresponding to titin A167 to the M2 region (Figure 1(a) ). A total of 22 interacting clones were identi®ed out of 1.6 Â 10 6 screened clones. Four of the 22 clones could be con®rmed by beta-galactosidase assays, and two of these four were shown by sequencing to encode the novel RING ®nger protein MURF-1 (for recent identi®cation of a MURF, see Spencer et al. 18 for a review on RING ®nger proteins, see Jackson et al.) . 19 The characterization of the two other interacting clones, i.e. whether they correspond to truly interacting clones or are false positives, is currently under study. To determine more precisely the MURF-1 binding site on titin, titin bait deletion constructs Á1 to Á8 were tested. This showed that A168/A169 was necessary and suf®-cient for the interaction with MURF-1 (Figure 1(a) and (b)). Next, we determined the full-length cDNA sequence of MURF-1 by screening human heart and skeletal muscle cDNA libraries (see Materials and Methods). Its full length cDNA is 1.9 kb in length and encodes a 38 kDa RING ®nger protein (see below), whose RING ®nger B-box domain is located at the N terminus (Figures 2 and  3 ). Yeast two-hybrid interaction experiments using deletion constructs of MURF-1 with A168/A169 preys indicated that a central 144-residue segment of MURF-1 was required for its interaction with titin A168/A169 (Figure 1(c) ).
Finally, we studied the interaction of the titin A168/A169 domains with MURF-1 by GSTpulldown assays. This in vitro assay con®rmed that A168/A169 titin sequences interacted with MURF-1 (Figure 1(d) ).
MURFs, a gene family encoding muscle specific RING finger proteins
To identify proteins in addition to titin that may interact with MURF-1, we constructed a bait plasmid encoding 1.02 kb MURF-1 cDNA, containing the complete open reading frame of MURF-1 ( Figure 2 ). When screening adult skeletal muscle cDNA libraries (9.2 Â 10 5 clones), two MURF-1 prey clones were identi®ed, suggesting that MURF-1 may indeed homo-dimerize as indicated by its coiled-coil potential (Figure 2(a) ). In vitro GST-pulldown assays using 35 S-labelled MURF-1 con®rmed that MURF-1 indeed interacts with itself, presumably by forming homo-dimers (Figure 2(b) ).
By screening heart cDNA libraries with MURF-1 baits (2.8 Â 10 6 clones), we identi®ed 11 positive clones. Among them, three clones were derived from the same gene and encoded a novel RING ®nger protein. This novel RING ®nger protein is 62 % homologous to MURF-1 (Figure 3(a) ), and is referred to here as MURF-2. Furthermore, we constructed a bait plasmid using full-length MURF-2 cDNA, and screened human skeletal muscle, brain, and mouse embryo cDNA libraries (5.1 Â 10 5 , 2.1 Â 10 6 , and 6.5 Â 10 5 clones, respectively), which identi®ed several positive clones. One of these prey clones coded for a third RING ®nger protein which shares 77 % and 65 % homology with MURF-1 and MURF-2, respectively ( Figure 3(a) ). Data library searches revealed that this clone corresponded to the``MURF'' described recently by Spencer et al. 18 This MURF protein is referred to here as MURF-3 to distinguish it from the titin binding MURF-1 and from the MURF-2 that interacts with both MURF-1 and MURF-3 ( Figure 2 ). Other interacting clones from this screen are currently being analyzed.
Sequence comparison of MURF-1,2,3 showed that their N-terminal 140 residues are 82 % to 85 % homologous and share an N-terminal RING domain, a Zn-binding B-box motif, and a MURF family-speci®c conserved box (MFC). Within their central regions, MURFs also share two coiled-coil dimerization motif boxes (Figures 1(c) and 3(a)). The C-terminal acidic residue-rich domains within the MURF-family are somewhat more divergent and also subject to differential splicing events (Figure 2 (Table 1) . Therefore, evolutionary constraints are likely to be responsible for maintaining the high degree of conservation among members of the MURF family, which is remarkably high particularly in the MURF-family speci®c MFC-box (Figure 3(a) ).
To determine the tissue distribution of MURF transcripts, MURF-1,2,3-speci®c probes were hybridized to multiple tissue poly(A) RNA dot blots ( Figure 4 ). MURF-1 and MURF-3 are musclespeci®c, whereas low levels of MURF-2 transcripts were detected in liver in addition to striated muscles. MURF-1 transcript appeared to be expressed throughout all developmental stages in the striated muscle tissues, whereas MURF-2 transcript is most abundant in the fetal heart. MURF-3 transcript levels appeared to be upregulated during striated muscle development (Figure 4 ).
Sarcomeric and cellular localization of MURF-1
To determine the cellular localization of MURFs, antibodies were raised to MURF-1, 2 and 3 speci®c peptides. Immunoelectron microscopy with MURF-1 speci®c antibodies detected MURF epitopes 100 nm away from the center of the M-line within the periphery of the M-line lattice ( Figure 5(a) and (c) ). This localization coincides with that of the titin kinase domain, as determined previously with titin kinase domain speci®c antibodies. 8 In addition to M-line labelling, MURF-1 epitopes were also detected within the periphery of the Z-line. Indirect immuno¯uorescence microscopy on rat heart isolated myo®brils and whole heart tissue sections detected both soluble and sarcomeric bound forms of MURF-1 ( Figure 6 ). To determine the location of MURF-1 in the sarcomere, double immuno¯uorescence staining was performed with the Z line markers anti-titin T12 or anti-sarcomeric a-actinin antibodies. It is interesting that in some instances, we detected most MURF-1 labelling at the M-line together with soluble forms (rat heart isolated myo®brils, Figure 6 (a)). In other instances, we detected MURF-1 essentially at the Z line (rat heart tissue, Figure 6 (b), and rat psoas tissue, data not shown), suggesting that MURF-1 may target to different sarcomeric as well as cytoplasmic sites. The basis for these differential localization patterns is currently under investigation.
Our antibodies raised to MURF-2 did not detect speci®c labeling in adult cardiac and skeletal tissues, whereas in fetal heart tissues a diffuse labelling was detected (data not shown). At present we do not know if this re¯ects the lack of ef®cient epitope recognition by our antibody, or if MURF-2 is present in soluble form in fetal tissues. Finally, MURF-3 was recently found to colocalize with microtubules and with Z-lines in skeletal muscle. 18 
Discussion
Here, we describe the identi®cation of three highly related RING ®nger proteins by titin-based yeast two-hybrid screens. One of them is identical with the recently described MURF protein. 18 The three RING ®nger proteins discussed here represent a speci®c subgroup among all known RING ®nger proteins (Figure 3(b) ). Therefore, we suggest refering to all three proteins as MURFs. To distinguish the individual members of the MURF gene family, we propose to refer to the titin binding MURF as MURF-1, to the MURF expressed early during cardiac development as MURF-2, and ®nally, to refer to the recently described microtubule-associated protein }18 as MURF-3. The N-terminal regions of the three MURFs contain two potential initiation codons (Figure 3(a) ). To study from which ATG codon translation initiation may occur, EST entries in the public data libraries encoding the 5 H regions of mouse MURFs were analyzed. A partial cDNA for mouse MURF-2 was found to be poorly conserved to human MURF-2 upstream of the 3 H ATG (EST accession gbjAA840584.1jAA840584). In the mouse genomic sequence for MURF-1, a TATA box is located 30 base-pairs upstream of the second ATG codon (not shown). Therefore, translational initiation within the MURF family is likely to occur from the second ATG within the MURF open reading frames (see Figure 3 (a)). It remains to be seen if the upstream ATG codon may also serve as a second alternative initiation site. When searching the public databases with our human MURF-1,2,3 sequences, we noted a very high degree of conservation to MURF-like ESTs from other vertebrates (data not shown). However, we could not identify MURF homologs in the sequenced genomes from C. elegans and Drosophila melanogaster. 11, 20 It will be interesting to see if yeast two-hybrid studies using the twitchin and projectin kinase N-terminal¯anking domains as baits will also identify twitchin and projectin kinase domain associated proteins.
The localization of MURF-1 within the periphery of the M-line is consistent with its binding to the titin kinase region, whereas its presence in Z-lines in our study is surprising. However, recently, MURF-3 has also been localized to Z-lines. 18 The coiled-coil potentials in MURF1/MURF-3 suggest that both molecules may form heterodimers. Indeed, our GST pulldown assays detected the interaction of MURF-1 with MURF-3 (Figure 2(c) ). Therefore, we speculate that a fraction of MURF-1 targets to the M-line periphery via its interaction with titin A168/A169 sequences, whereas another fraction is bound to the Z-line by heterodimerization with MURF-3. MURF-3 in turn interacts with Z-line proteins. 18 It is interesting that in some sections about equal amounts of M-line and Z-line bound MURF-1 were detected ( Figure 5 ), whereas in others only Z-line bound MURF-1 was detected. This raises the interesting possibility that MURF-1 has multiple cellular localizations, with a variable, controlled distribution.
The interaction of MURF-1 both with the titin kinase¯anking sequences and with MURF-3, which is involved in microtubule dynamics, 18 may link titin-based and microtubule-based signaling pathways. For instance, it has previously been noted that the microtubule-stabilizing drug taxol induces postmitotic myoblasts to assemble interdigitating microtubule-myosin arrays, suggesting links between microtubular and sarcomeric assembly. 21 Also, the stability and composition of microtubules in heart muscle are dependent on stretch and ventricular ®lling. 22 Titin appears to be an excellent candidate for a myo®brillar-based stretch sensor, because its individual giant ®lamen-tous molecules span the entire half sarcomere, and form by their overlap in Z and M-lines a continuous ®lament system within the myo®bril. The titin kinase domain with its associated factor(s) such as MURF-1 is therefore emerging as a potential sensor. This could link myo®bril stretch to microtubule restructuring which is known to occur in pressure-induced cardiac hypertrophy. (a) MURF-1 is localized to the M-line region and is also found in soluble form in rat heart isolated myo®brils. Merged double immuno¯uorescence confocal micrograph of MURF-1 (green) and titin T12 (red) localization in rat heart myo®brils. (b) MURF-1 was sometimes localized exclusively in the Z-line region in rat heart tissue sections. Merged double immuno¯uorescence confocal micrograph of MURF-1 (green) and sarcomeric a-actinin (red) localization in rat heart sections. Arrows mark MURF-1 staining.
Titin and MURFs
Future studies are needed to address how the titin kinase and the MURF proteins cooperate in myo®brillar signal transduction. Potentially, the titin kinase domain may phosphorylate MURF-1, which then would operate downstream in the titin kinase signal pathway. Our preliminary in vitro studies using recombinant titin kinase and MURF-1 proteins have been unsuccessful in demonstrating speci®c phosphorylation of MURF-1 by titin (unpublished results). Therefore, at present, we favor a model in which MURF-1 may modulate the activity of the titin kinase domain, a domain that is tightly autoinhibited. 13 In this model, MURF-1 may present appropriate substrates to the titin kinase domain, similar to the roles of A-protein kinase asscociated proteins (AKAPs) in controlling protein kinase A activities and speci®ci-ties (for a review, see Dodge & Scott) . 23 Finally, it should be noted that, in many cases, RING domains mediate ubiquitin-transfer (for a review, see Freemont) . 24 This raises the interesting possibility that the association of MURFs with the M-line and Z-line regions (Figure 3 ) could link ubiquitin-transfer pathways to the titin ®lament system. At present, we are investigating whether such links exist and whether they may relate to the physiological turnover of titin in myo®brils.
Despite the discovery of a family of titin-kinase like domains in giant muscle proteins 9, 16 and the determination of the atomic structure of the titin kinase domain 14 the function of this catalytic domain has remained elusive. Novel insights into the function of the titin kinase signaling pathway may be derived from the present discovery and the future characterization of the MURF-1/titin kinase complex.
Materials and Methods

Yeast two-hybrid screens
The``bait'' cDNA fragments were inserted into the pAS2C-1 vector (Clontech, Palo Alto), and transformed into Saccharomyces cerevisiae, strain PJ69-4A. For screening, transformed PJ69-4A cells were further transformed with human skeletal muscle, heart, brain, or mouse embryo cDNA library in the pGAD10 or pACT2 vector (HL4010AB, HL4013AB, HL4004AB, or ML4013AH, respectively, Clontech, Palo Alto, CA). Candidate clones were rescued on SD-Leu, Trp, His, and Ade according to the manufacturer's manual (Clontech, Palo Alto, CA).`P rey'' plasmids of candidate clones were isolated, sequenced, and re-transformed into PJ69-4A with the bait plasmid to con®rm binding. All positive clones were further con®rmed by beta-galactosidase activity measured using chlorophenol red-beta-D-galactopyranoside (CPRG) as described by the manufacturer (Clontech, Palo Alto).
In vitro transcription/translation and GST pulldown experiments
The full-length MURF-1 sequence was inserted into a modi®ed pET9d vector lacking the His 6 tag. In vitro transcription and translation was carried out in the presence of [
35 S]methionine (Amersham Pharmacia Biotech, Sweden) using the TNT T7-coupled reticulocyte lysate system according to the manufacturer's description (Promega Corp. Madison, WI). For the homodimerization assay, full-length MURF-1 sequence was inserted into modi®ed pET9d to express a His6-GST-MURF-1 fusion peptide. The titin A168-A169 fragment corresponding to bp73,419-74,135 (human titin cDNA, EMBL data library accession X90568) was inserted into a modi®ed pET9d vector to express a His 6 -GST-A168/A169 fusion peptide. The constructs were transformed into BL21 codon plus cells (Stratagene, Heidelberg). Whole cell lysate in 2Â PBS was prepared as described by Studier et al. 25 GST fusion protein was immobilized on glutathione-Sepharose 4B beads (Amersham Pharmacia Biotech, Sweden) using approximately 100 ml of lysate on 50 ml of beads (50 % slurry) in 1 ml of coating buffer (2Â PBS, 1 % (v/v) Triton X-100) for one hour. The beads were washed three times with coating buffer and resuspended in binding buffer (40 mM Tris (pH 7.4), 400 mM NaCl, 10 % (w/v) glycerol, 0.2 % (w/v) Igepal CA630). Then 8 ml of in vitro translated protein was added to 50 ml of beads coated with 20 mg of GST fusion protein in 500 ml of binding buffer. The mixture was incubated for 1.5 hours at 4 C and washed three times with binding buffer and resuspended in SDS sample buffer. The protein complexes were separated by SDS-15 % PAGE. The gels were stained with Coomassie blue, treated with Amplify (Amersham Pharmacia Biotech, Sweden), dried and exposed using BioMax MR-1 ®lm (Eastman Kodak, Rochester, NY). The results of the Coomassie blue staining were used to con®rm that equal amounts of each GST-protein in the different reactions were bound to the glutathione beads (data not shown). GST and a His 6 -GST fusion protein of the titin N2A region (bp15598-15966 of x90569) were used as control peptides.
cDNA cloning
The two-hybrid prey cDNA clones for MURF-1,2,3 corresponded to partial cDNAs, as indicated by open reading frames at their 5 H ends. Therefore, MURF-1, 2 and 3 probes were hybridized to a human cardiac cDNA library (Stratagene #936208). From a total of 400,000 screened clones, 24 positive clones were picked. Their cDNA inserts were ampli®ed using combinations of MURF-speci®c internal primers with Bluescript (lambda-ZAP) derived vector primers. The largest fragments extending into the 5 H and 3 H directions were sequenced. Two or more independent fragments were sequenced for each extension to establish the correct open reading frame. For MURF-2 and MURF-3 splice isoform variants were noted within the C-terminal region (see annotations to AJ291712 and AJ291714, respectively). The human full-length cDNA sequences encoding MURF-1, 2 and 3 have been deposited in the EMBL data library under accession numbers, AJ291713, AJ291712, AJ291714, respectively.
Northern blot analysis
To determine the tissue distribution and message sizes of MURFs, MURF-1,2,3 cDNA fragments were randomly labeled with 32 P (Amersham, Multiprime DNA labelling systems), and probes were hybridized to multiple tissue dot and Northern blots (Clontech, RNA Master Blot 2 and MTN 1 Blot). To avoid illegitimate crosshybridization, probes were selected from the 3 H UTR regions. To allow for a semi-quantitative comparison, three separate RNA Master Blot 2 ®lters were purchased from the manufacturer, hybridized, washed and exposed to X-ray ®lms, in parallel under identical conditions.
Gene mapping
The localization of the MURF-1,2,3 gene loci in human was determined by the radiation hybrid method 26 on the Stanford G3 RH panel, using speci®c primer pairs. MURF-1 was localized to region 1p31.1-p33, 22 cR from SHGC-56764, 26 cR from SHGC-37693, and 25 rR from SHGC-19875.
MURF-3 was located 7 cR from SHGC-14626 and 14 cR from SHGC-11736. These markers reside within a 2 cM (436 cR) region between D2S171 and D2S165 on 2p21-16. MURF-2 was localized to 8q12-13, 19 cR from SHGC-12488, SHGC-3914 and SHGC-3855. SHGC-3914 localizes between markers D8S1841 and D8S1797 on the Stanford G3 map, whereas SHGC-12488 localizes between D8S1841 and D8S553 in the NCBI map. This presumably indicates discrepancies of microsatellite assignments in different chromosomal maps at this stage.
Protein expression and antibody production
For obtaining MURF-1 speci®c antisera, a fragment encoding its C-terminal 176 residues was ampli®ed from total skeletal muscle cDNA by PCR, using the following primers: MURF-1S: tttccatg GCG GGG AAT GAC CGT GTG CAG ACC ATC ATC; MURF-1R: tttggtacc TCC AGC TCC TTA CTG GTG TCC TTC TTC CTT. This fragment excludes the highly conserved N-terminal RING ®nger and MURF family box motifs, therefore reducing the risk of crossreaction to MURF-2,3. The fragment was cloned into the pET9D expression vector and was expressed as a His 6 fusion protein in BL21-DE3 cells. 27 The soluble fraction of the expressed polypeptide was puri®ed using Ni-NTA resin (Qiagen, Du È sseldorf, Germany) as speci®ed by the manufacturer. Polyclonal antibodies to the peptide were generated in rabbit by Eurogentec (Bruxelles, Belgium), and the speci®c IgG fraction was puri®ed by af®nity chromatography. Western blots con®rmed speci®city of the obtained antisera to MURF-1 (data not shown).
Immunoelectron microscopy
Muscle strips ($200 mm in diameter) were dissected from the wall muscle of mouse left ventricle. The strips were skinned overnight in relaxing solution with 1 % Triton X-100 and were then extensively washed with relaxing solution. The strips were then stretched (at $0.25 mm/sarcomere) to different lengths, held in that state for about two minutes and then ®xed, incubated for one hour in PBS supplemented with 1 % bovine serum albumin, immuno-labelled, embedded, and processed for electron microscopy. We used af®nity puri®ed anti-MURF-1 antibodies (50 mg/ml), and as secondary antibodies nanogold anti-rabbit IgG (Nanoprobes, Inc.). To increase sensitivity a silver-enhancement technique was used as per the manufacturer's protocol. For further details see Trombita Âs et al.
28
Immunofluorescence microscopy studies Isolated rat heart myo®brils 29 or 10 mm frozen sections of adult rat heart were ®xed in 2 % (v/v) formaldehyde/ PBS for ten minutes, washed in PBS, and permeabilized in 0.2 % Triton X-100/PBS for 15 minutes. The myo®brils and sections were pre-incubated in 2 % (w/v) bovine serum albumin, 1 % (v/v) normal donkey serum/PBS for one hour at room temperature to minimize non-speci®c binding of antibodies. The sections and myo®brils were incubated with af®nity puri®ed anti-MURF-1 antibodies (10 mg/ml), followed by Texas Red-conjugated goat anti-rabbit IgG (1:700) (Jackson Immunoresearch Laboratories, Inc.,West Grove, PA). The tissue was then incubated with anti-titin T12 monoclonal antibody (1:200) (Boehringer-Mannhein Biochemicals) or with sarcomeric a-actinin monoclonal antibody (1:2000)(EA-53; Sigma; St. Louis, MO) followed by Cy-2-conjugated goat anti-mouse IgG (1:600) (Pierce; Rockford, IL). No differences in staining patterns were observed between frozen sections and isolated myo®-brils. Sections stained with the secondary antibodies alone consistently revealed negligible¯uorescence. Stained sections were analyzed on a Leica TCS 4D laser scanning confocal microscope (Arizona Research Laboratory, Division of Biotechnology, University of Arizona, Tucson, AZ) using a 100Â NA 1.4 oil immersion objective. Simultaneous two channel recording was performed with a pinhole size of 90 mm. All Figures are derived from a single optical section. Images were processed and merged using Adobe Photoshop software and printed using a Codonics NP1600 dye sublimation printer.
